Faus Moliner participates in the Chambers & Partners Guide to Pharmaceutical Advertising 2025

Anna Gerbolés and Laia Rull have contributed to the chapter dedicated to Spain, providing an analysis of the legal framework regulating the advertising of medicines and its practical application.

The “Law & Practice” section offers key information to help companies operating in Spain navigate the legal system in terms of pharmaceutical advertising, transparency and anti-bribery measures.

On the other hand, the “Trends & Developments” section explores the latest developments in the advertising of medicines in Spain, providing relevant context on upcoming regulatory changes and their impact on the industry.